The semifinals playoff series has one more game in Las Vegas before moving to the Fever’s home court for Game 3, which tips off at 7:30 p.m. Friday at Gainbridge Fieldhouse.
Eli Lilly and Co. this month launched a public awareness campaign called Brain Health Matters, which features actress Julianne Moore urging people to be proactive as they age to lower their risk of dementia, including Alzheimer’s disease.
Democratic leaders are adamantly opposed to the bill and are threatening a government shutdown if Republicans don’t let them have a say on the measure.
Additionally, some who had left the Leonard Street camp after initial closure notices and had relocated elsewhere in the neighborhood are also being connected to housing and services.
Indianapolis-based The September Group purchased the companies that would eventually create WSI—which offers secure audio and video recording solutions for public safety and child welfare organizations—in 2020.
Every dollar wasted on this broken system is a dollar not spent solving the hundreds of murders and sexual assaults that leave victims without justice.
The call might offer clues about whether the two leaders could meet in person to hash out a final agreement to end their trade war and provide clarity on where relations between the world’s two superpowers may be headed.
As a critical vote by the City-County Council approaches on whether to rezone 467 acres for Google’s proposed billion-dollar data center, the local school district has changed its stance on the project.
The Fever hosted their first playoff game since 2016 and fed off the energy of the rowdy crowd at Gainbridge Fieldhouse to earn their first postseason win since Oct. 11, 2015.
Using $10 million appropriated by the Legislature, the state’s Office of Commerce says it will provide grants to employers to offer training with the goal of building skills to match the needs of their open positions.
The Food and Drug Administration on Tuesday posted more than 100 letters to various drug and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered on lower-cost versions of blockbuster obesity injections.
